Beirne Wealth Consulting Services, LLC Altimmune, Inc. Transaction History

Beirne Wealth Consulting Services, LLC

$281 Billion
Q1 2025

A detailed history of Beirne Wealth Consulting Services, LLC transactions in Altimmune, Inc. stock. As of the latest transaction made, Beirne Wealth Consulting Services, LLC holds 294,458 shares of ALT stock, worth $1.6 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares

294,458

Previous 294,458 -0.0%

Holding current value

$1.6 Million

Previous $2.12 Billion 30.65%

% of portfolio

0.52%

Previous 0.77%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$6.02 - $9.85 $50,218 - $82,168	-8,342 Reduced 2.75%	294,458 $2.12 Billion
Q3 2024 Nov 07, 2024	BUY	$5.5 - $8.1 $137,500 - $202,500	25,000 Added 9.0%	302,800 $1.86 Billion
Q2 2024 Aug 12, 2024	BUY	$5.91 - $10.23 $29,550 - $51,150	5,000 Added 1.83%	277,800 $1.85 Billion
Q1 2024 May 13, 2024	SELL	$8.22 - $13.81 $254,820 - $428,110	-31,000 Reduced 10.2%	272,800 $2.78 Billion
Q4 2023 Feb 06, 2024	BUY	$2.14 - $11.62 $116,373 - $631,895	54,380 Added 21.8%	303,800 $3.42 Billion
Q1 2023 May 10, 2023	BUY	$4.19 - $16.83 $51,956 - $208,691	12,400 Added 5.23%	249,420 $1.05 Billion
Q4 2022 Feb 08, 2023	SELL	$8.74 - $16.45 $400,292 - $753,410	-45,800 Reduced 16.19%	237,020 $3.9 Million
Q3 2022 Nov 07, 2022	SELL	$10.67 - $22.41 $19,494 - $40,943	-1,827 Reduced 0.64%	282,820 $3.61 Million
Q2 2022 Jul 13, 2022	BUY	$3.94 - $11.77 $397,179 - $1.19 Million	100,807 Added 54.83%	284,647 $3.33 Million
Q1 2022 May 10, 2022	BUY	$5.9 - $9.45 $277,300 - $444,149	47,000 Added 34.35%	183,840 $1.12 Million
Q4 2021 Feb 03, 2022	BUY	$8.69 - $12.48 $42,581 - $61,152	4,900 Added 3.71%	136,840 $1.26 Million
Q3 2021 Nov 09, 2021	SELL	$8.43 - $16.81 $15,426 - $30,762	-1,830 Reduced 1.37%	131,940 $1.49 Million
Q2 2021 Aug 10, 2021	BUY	$9.85 - $16.46 $206,850 - $345,660	21,000 Added 18.62%	133,770 $1.32 Million
Q1 2021 May 17, 2021	BUY	$12.71 - $24.31 $464,486 - $888,408	36,545 Added 47.94%	112,770 $1.59 Million
Q4 2020 Feb 03, 2021	BUY	$7.84 - $14.22 $597,604 - $1.08 Million	76,225 New	76,225 $860,000

Others Institutions Holding ALT

# of Institutions

212

Shares Held

39.4M

Call Options Held

1.93M

Put Options Held

1.4M

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $266M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.

Account

Beirne Wealth Consulting Services, LLC Altimmune, Inc. Transaction History